TORONTO, April 16, 2012 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, announced that an abstract entitled “Blood signatures for early liver cancer detection in patients with chronic hepatitis B” has been selected for a poster presentation at the annual meeting of the American Society of Clinical Oncology (“ASCO”) to be held at McCormick Place in Chicago, IL from June 1-5, 2012.
